What is CVE-2020-16247?

CVE-2020-16247 is a medium-severity vulnerability in Philips Clinical Collaboration Platform, classified under CWE-16. CVSS score: 6.8/10. Published 2020-09-18.

How severe is CVE-2020-16247?

Medium severity. CVSS v3 base score is 6.8 out of 10.

Vulnerability in Philips Clinical Collaboration Platform

CVE-2020-16247

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.

EPSS: 0.000 (13.8th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.8 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H.

Affected products

Philips Clinical Collaboration Platform — versions 0

Weakness classification (CWE)

CWE-16

References

us-cert.cisa.gov/ics/advisories/icsma-20-261-01 (x_refsource_MISC)
www.philips.com/a-w/security/security-advisories/product-security-2020.html

Frequently asked questions

What is CVE-2020-16247?: CVE-2020-16247 is a medium-severity vulnerability in Philips Clinical Collaboration Platform, classified under CWE-16. CVSS score: 6.8/10. Published 2020-09-18.
How severe is CVE-2020-16247?: Medium severity. CVSS v3 base score is 6.8 out of 10.